We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AXLA Axcella Health Inc

0.00 (0.0%)
Last Updated: 19:00:00
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 4.50
Ask Price 4.51
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Axcella Health Inc AXLA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 4.58 19:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 2.5875 - 41.25
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 4.58 USD

Axcella Health Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
13.5M 2.95M - 0 -81.19M -27.54 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Axcella Health News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No AXLA Message Board. Create One! See More Posts on AXLA Message Board See More Message Board Posts

Historical AXLA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.555.604.554.6319,845-0.97-17.48%
1 Month5.426.754.075.2830,779-0.84-15.5%
3 Months9.44541.254.0722.3210,581,618-4.87-51.51%
6 Months10.042541.252.587515.7810,326,865-5.46-54.39%
1 Year28.0041.252.587515.635,533,879-23.42-83.64%
3 Years143.50171.002.587518.701,927,673-138.92-96.81%
5 Years378.00398.502.587522.701,302,062-373.42-98.79%

Axcella Health Description

Axcella Health Inc a biotechnology company focused on treating complex diseases and improve health using endogenous metabolic modulator, or EMM, compositions. Its product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios to simultaneously impact multiple biological pathways. The company's pipeline includes lead therapeutic candidates, AXA1665 for the reduction in risk of recurrent overt hepatic encephalopathy, and AXA1125 for non-alcoholic steatohepatitis.

Your Recent History

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |